Safety and efficacy of the stabilizer device using in endovascular therapy - SD-01 Trial

Sakai Nobuyuki0 个研究点目标入组 30 人开始时间: 2022年6月22日最近更新: 2023年10月17日

试验速览

暂无简介。

•1 Patients aged between 20years and 80years old at the time of concent acquisition
•2 modified Rankin Scale is 3 or less
•3 Patients with cerebral aneurysm or cerebral artery stenosis who cannot deliver therapeutic medical devices by conventional methods including replacement during endovascular treatment
•4 patients who concented to the study in writing.

•1.Heparin cannot be administered for medical reasons
•2.It is difficult to follow up 7 days after surgery
•3.Have a history of severe contrast agent allergies
•4.The following patients who are contraindicated in the clinical trial device summary
•(1) Patients with allergies to metals contained in the investigational equipment The following patients who are contraindicated in the investigational equipment summary
•(2) Patients with carotid artery dissection, carotid cervical obstruction or vasculitis
•5.Participating in other clinical trials
•6.Pregnant or breastfeeding, or unwilling to use contraception during the trial (female only)
•7.In addition, the investigator or the investigator has determined that it is inappropriate for conducting this clinical trial.

发起方

Sakai Nobuyuki